Eli Lilly & Co.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
JNJJohnson & Johnson 1.28%165.280.7%$1347.62m
LLYEli Lilly & Co. 1.08%325.011.1%$1079.18m
ABBVAbbVie, Inc. 2.05%141.151.9%$869.70m
PFEPfizer Inc. 0.84%44.510.9%$804.85m
BMYBristol-Myers Squibb Co. 1.29%71.441.0%$782.64m
MRKMerck & Co., Inc. 0.89%88.330.7%$716.70m
AZNAstraZeneca Plc 2.41%56.891.0%$396.84m
ALNYAlnylam Pharmaceuticals, Inc. -0.73%195.368.2%$215.81m
GSKGSK Plc 2.31%30.950.3%$214.50m
NVSNovartis AG 2.22%78.370.2%$206.13m
GBTGlobal Blood Therapeutics, Inc. 0.01%68.495.4%$191.19m
IDXXIDEXX Laboratories, Inc. 3.56%348.663.9%$190.84m
HZNPHorizon Therapeutics Plc 1.65%65.325.4%$176.51m
ATXIAvenue Therapeutics, Inc. 19.90%13.800.0%$167.02m
SRPTSarepta Therapeutics, Inc. -0.83%109.0312.4%$135.60m

Company Profile

Eli Lilly & Co. engages in the discovery, development, manufacture and sale of pharmaceutical products. The firm's products consist of Diabetes, Oncology, Immunology, Neuroscience, and Other therapies. The Diabetes products include Baqsimi, Basaglar, Humalog, Humulin, Jardiance, Lyumjev, Trajenta, and Trulicity. The Oncology products consist of Alimta, Cyramza, Erbitux, Retevmo, Tyvyt, and Verzenio. The Immunology products include Olumiant and Taltz. The Neuroscience products consist of Cymbalta, Emgality, Reyvow, and Zyprexa. The Other therapies include Bamlanivimab, Cialis, and Forteo. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.